van de Locht LT - Search Results

1

Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia.

van de Locht LT, Smetsers TF, Wittebol S, Raymakers RA, Mensink EJ. van de Locht LT, et al. Leukemia. 1994 Oct;8(10):1780-4. Leukemia. 1994. PMID: 7523801

2

In AML t(8;21) colony growth of both leukemic and residual normal progenitors is restricted to the CD34+, lineage-negative fraction.

Wittebol S, Raymakers R, van de Locht L, Mensink E, de Witte T. Wittebol S, et al. Leukemia. 1998 Nov;12(11):1782-8. doi: 10.1038/sj.leu.2401178. Leukemia. 1998. PMID: 9823954

3

Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.

Smetsers TF, van de Locht LT, Pennings AH, Wessels HM, de Witte TM, Mensink EJ. Smetsers TF, et al. Among authors: van de locht lt, de witte tm. Leukemia. 1995 Jan;9(1):118-30. Leukemia. 1995. PMID: 7845006

4

Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.

Smetsers TF, Skorski T, van de Locht LT, Wessels HM, Pennings AH, de Witte T, Calabretta B, Mensink EJ. Smetsers TF, et al. Among authors: van de locht lt, de witte t. Leukemia. 1994 Jan;8(1):129-40. Leukemia. 1994. PMID: 8289478

5

Degradable dU-based DNA template as a standard in real-time PCR quantitation.

Pennings JL, Van De Locht LT, Jansen JH, Van der Reijden BA, De Witte T, Mensink EJ. Pennings JL, et al. Among authors: van de locht lt. Leukemia. 2001 Dec;15(12):1962-5. doi: 10.1038/sj.leu.2402290. Leukemia. 2001. PMID: 11753618

6

Molecular Diagnosis of Acute Myeloid Leukemia with Maturation, FAB-Type M2.

Mensink EJ, van de Locht LT. Mensink EJ, et al. Among authors: van de locht lt. Methods Mol Med. 1996;6:37-45. doi: 10.1385/0-89603-341-4:37. Methods Mol Med. 1996. PMID: 21380695

7

Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow.

Van Dijk JP, Knops GH, Van De Locht LT, Menke AL, Jansen JH, Mensink EJ, Raymakers RA, De Witte T. Van Dijk JP, et al. Among authors: van de locht lt. Br J Haematol. 2002 Sep;118(4):1027-33. doi: 10.1046/j.1365-2141.2002.03728.x. Br J Haematol. 2002. PMID: 12199781 Free article.

8

PCR detection of a BglII polymorphism in intron I of the human p53 gene (TP53).

Willems PM, Meyerink JP, van de Locht LT, Smetsers TF, de Vries N, Mensink EJ. Willems PM, et al. Among authors: van de locht lt, de vries n. Nucleic Acids Res. 1992 Mar 11;20(5):1172. doi: 10.1093/nar/20.5.1172-a. Nucleic Acids Res. 1992. PMID: 1347935 Free PMC article.

9

Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis.

van de Locht LT, Kuypers AW, Verbruggen BW, Linssen PC, Nováková IR, Mensink EJ. van de Locht LT, et al. Thromb Haemost. 1995 Nov;74(5):1276-9. Thromb Haemost. 1995. PMID: 8607109

10

An antisense Bcr-Abl phosphodiester-tailed methylphosphonate oligonucleotide reduces the growth of chronic myeloid leukaemia patient cells by a non-antisense mechanism.

Smetsers TF, Linders EH, van de Locht LT, de Witte TM, Mensink EJ. Smetsers TF, et al. Among authors: van de locht lt, de witte tm. Br J Haematol. 1997 Feb;96(2):377-81. doi: 10.1046/j.1365-2141.1997.d01-2035.x. Br J Haematol. 1997. PMID: 9029029 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters